Dr. Karen Tedesco
Claim this profileUSO - New York Oncology Hematology
Studies Breast Cancer
6 reported clinical trials
14 drugs studied
Area of expertise
1Breast Cancer
HER2
Stage IV
lymph node
Affiliated Hospitals
Clinical Trials Karen Tedesco is currently running
Genomic Testing
for Breast Cancer
The FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry. All patients with stage I to III breast cancer who receive MammaPrint® and BluePrint testing on a primary breast tumor are eligible for entry into the FLEX Registry, which is intended to enable additional study arms at low incremental effort and cost. FLEX Registry will utilize an adaptive design, where additional targeted substudies and arms can be added after the initial study is opened.
Recruiting1 award N/A3 criteria
GLSI-100
for HER2 Positive Breast Cancer
This is a prospective, randomized, double-blinded, placebo-controlled, multi-center, Phase 3 study of GLSI-100 immunotherapy in HLA-A\*02 positive and HER2/neu positive subjects who are at high risk for disease recurrence and have completed both neoadjuvant and postoperative adjuvant standard of care therapy. Treatment consists of 6 intradermal injections, Primary Immunization Series (PIS), over the first 6 months of treatment and 5 booster intradermal injections spaced 6 months apart. A third open-label arm will explore GLSI-100 immunotherapy in non-HLA-A\*02 positive and HER2/neu positive subjects.
Recruiting1 award Phase 36 criteria
More about Karen Tedesco
Clinical Trial Related8 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Karen Tedesco has experience with
- Bintrafusp Alfa
- Abemaciclib
- Anastrozole
- Exemestane
- Imlunestrant
- Letrozole
Breakdown of trials Karen Tedesco has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Karen Tedesco specialize in?
Karen Tedesco focuses on Breast Cancer and other conditions. In particular, much of their work with Breast Cancer has involved HER2 patients, or patients who are Stage IV.
Is Karen Tedesco currently recruiting for clinical trials?
Yes, Karen Tedesco is currently recruiting for 3 clinical trials in Albany New York. If you're interested in participating, you should apply.
Are there any treatments that Karen Tedesco has studied deeply?
Yes, Karen Tedesco has studied treatments such as Bintrafusp alfa, Abemaciclib, Anastrozole.
What is the best way to schedule an appointment with Karen Tedesco?
Apply for one of the trials that Karen Tedesco is conducting.
What is the office address of Karen Tedesco?
The office of Karen Tedesco is located at: USO - New York Oncology Hematology, Albany, New York 12206 United States. This is the address for their practice at the USO - New York Oncology Hematology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.